302 related articles for article (PubMed ID: 33508387)
1. The long-term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo.
Ju HJ; Han JH; Kim MS; Lee SH; Shin JW; Choi M; Jeong KH; Han TY; Choi CW; Lee HJ; Oh SH; Lee SH; Kim DH; Shin J; Lee JH; Kim SS; Kang HY; Chang SE; Kim JS; Lee DY; Choi GS; Suh DH; Chan Kim Y; Park CJ; Kim KH; Lee AY; Chan Park K; Lee MH; Bae JM;
J Am Acad Dermatol; 2021 Jun; 84(6):1619-1627. PubMed ID: 33508387
[TBL] [Abstract][Full Text] [Related]
2. Evaluation for Skin Cancer and Precancer in Patients With Vitiligo Treated With Long-term Narrowband UV-B Phototherapy.
Bae JM; Ju HJ; Lee RW; Oh SH; Shin JH; Kang HY; Park JH; Kim HJ; Jeong KH; Lee HJ; Lee S; Kim DH; Lee DY; Kim YC; Choi GS; Kim KH; Park CJ; Choi CW;
JAMA Dermatol; 2020 May; 156(5):529-537. PubMed ID: 32159729
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of 308-nm excimer laser/light (EL) and topical agent combination therapy versus EL monotherapy for vitiligo: A systematic review and meta-analysis of randomized controlled trials (RCTs).
Bae JM; Hong BY; Lee JH; Lee JH; Kim GM
J Am Acad Dermatol; 2016 May; 74(5):907-15. PubMed ID: 26785803
[TBL] [Abstract][Full Text] [Related]
4. Effect of topical calcineurin inhibitors as monotherapy or combined with phototherapy for vitiligo treatment: a meta-analysis.
Dang YP; Li Q; Shi F; Yuan XY; Liu W
Dermatol Ther; 2016; 29(2):126-33. PubMed ID: 26460804
[TBL] [Abstract][Full Text] [Related]
5. Incidence of skin malignancies in patients with vitiligo or psoriasis who received narrowband ultraviolet B phototherapy (308 nm/311 nm): A retrospective review of 3730 patients.
Chia BKY; Yew YW; Zhao X; Chong WS; Thng TGS
Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):343-350. PubMed ID: 36345565
[TBL] [Abstract][Full Text] [Related]
6. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
Li R; Qiao M; Wang X; Zhao X; Sun Q
Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
[TBL] [Abstract][Full Text] [Related]
7. A review of monochromatic excimer light in vitiligo.
Park KK; Liao W; Murase JE
Br J Dermatol; 2012 Sep; 167(3):468-78. PubMed ID: 22524428
[TBL] [Abstract][Full Text] [Related]
8. A combination of excimer laser treatment and topical tacrolimus is more effective in treating vitiligo than either therapy alone for the initial 6 months, but not thereafter.
Park OJ; Park GH; Choi JR; Jung HJ; Oh ES; Choi JH; Lee MW; Chang SE
Clin Exp Dermatol; 2016 Apr; 41(3):236-41. PubMed ID: 26299799
[TBL] [Abstract][Full Text] [Related]
9. This Month in JAAD: June 2021.
Elston D
J Am Acad Dermatol; 2021 Jun; 84(6):1542. PubMed ID: 33972026
[No Abstract] [Full Text] [Related]
10. Topical treatment and combination approaches for vitiligo: new insights, new developments.
Hossani-Madani AR; Halder RM
G Ital Dermatol Venereol; 2010 Feb; 145(1):57-78. PubMed ID: 20197746
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcomes of vitiligo in Asian children.
Tay EY; Chong CLV; Chong WJJP; Gan YE; Chuah SY; Tan WDV; Thng TGS
Pediatr Dermatol; 2018 Mar; 35(2):265-267. PubMed ID: 29436008
[TBL] [Abstract][Full Text] [Related]
12. Study the effect of erbium:YAG laser plus topical 5-flurouracil in stable vitiligo resistant to NB-UVB phototherapy.
Doghaim NN; El-Tatawy RA; Ismail MA; Ali DAM; El Attar YA
J Cosmet Dermatol; 2020 Jan; 19(1):122-130. PubMed ID: 31571367
[TBL] [Abstract][Full Text] [Related]
13. Vitiligo: an update on systemic treatments.
Searle T; Al-Niaimi F; Ali FR
Clin Exp Dermatol; 2021 Mar; 46(2):248-258. PubMed ID: 33350506
[TBL] [Abstract][Full Text] [Related]
14. Vitiligo: An Updated Narrative Review.
Leung AKC; Lam JM; Leong KF; Hon KL
Curr Pediatr Rev; 2021; 17(2):76-91. PubMed ID: 33302860
[TBL] [Abstract][Full Text] [Related]
15. Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas.
Vachiramon V; Chaiyabutr C; Rattanaumpawan P; Kanokrungsee S
Lasers Surg Med; 2016 Feb; 48(2):197-202. PubMed ID: 26175036
[TBL] [Abstract][Full Text] [Related]
16. Risk of skin cancer after ultraviolet phototherapy in patients with vitiligo: a systematic review and meta-analysis.
Wu YH; Chou CL; Chang HC
Clin Exp Dermatol; 2022 Apr; 47(4):692-699. PubMed ID: 34762747
[TBL] [Abstract][Full Text] [Related]
17. No evidence of increased cancer incidence in children using topical tacrolimus for atopic dermatitis.
Paller AS; Fölster-Holst R; Chen SC; Diepgen TL; Elmets C; Margolis DJ; Pollock BH
J Am Acad Dermatol; 2020 Aug; 83(2):375-381. PubMed ID: 32246968
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of early treatment in segmental vitiligo: retrospective study according to disease duration.
Park JH; Park SW; Lee DY; Lee JH; Yang JM
Photodermatol Photoimmunol Photomed; 2013 Apr; 29(2):103-5. PubMed ID: 23458396
[TBL] [Abstract][Full Text] [Related]
19. Association between exposure to topical tacrolimus or pimecrolimus and cancers.
Hui RL; Lide W; Chan J; Schottinger J; Yoshinaga M; Millares M
Ann Pharmacother; 2009 Dec; 43(12):1956-63. PubMed ID: 19903860
[TBL] [Abstract][Full Text] [Related]
20. Comparative study between excimer light and topical antioxidant versus excimer light alone for treatment of vitiligo.
Soliman M; Samy NA; Abo Eittah M; Hegazy M
J Cosmet Laser Ther; 2016; 18(1):7-11. PubMed ID: 26052813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
